According to Advaxis's latest financial reports and stock price the company's current number of shares outstanding is 4,784,474. At the end of 2023 the company had 4,784,474 shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.
Year | Shares Outstanding | Change |
---|---|---|
2023 | 4.78 M | 64.9% |
2022 | 2.9 M |
Company | Shares Outstanding | differencediff. | Country |
---|---|---|---|
Genocea Biosciences
GNCA | 71,120,000 | 1,386.47% | ๐บ๐ธ USA |
Inovio Pharmaceuticals INO | 22,385,229 | 367.87% | ๐บ๐ธ USA |
Heska Corporation
HSKA | 10,390,000 | 117.16% | ๐บ๐ธ USA |